核心外气凝设计用于增强口服胰岛素的输送
Gozde Ozesme Taylan1, Carlos Illanes-Bordomás2, Ozge Guven3
1Department of Biotechnology, Graduate School of Natural and Applied Sciences, Middle East Technical University, Ankara, Turkey.
International journal of pharmaceutics
|December 7, 2024
概括
新的气凝载体为患者提供了友好的胰岛素口服输送,提高了封装效率和控制在肠道中的释放,与传统注射不同.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 基于蛋白质的疗法通常需要注射,导致患者的不适和频繁的管理.
- 口服蛋白质的输送面临着诸如胃环境中的降解和吸收不良等挑战.
- 气凝具有高孔径和高表面积,为口服蛋白质疗法提供了一个新的平台.
研究的目的:
- 开发和描述基于天然多糖的气凝,用于口服胰岛素的输送.
- 为了比较常规和核心外气凝结构,以增强蛋白质封装.
- 为了评估从开发的气凝中释放的胰岛素的体外释放特征.
主要方法:
- 使用超临界二氧化碳 (sc-CO2) 干燥酸盐凝珠合成的气凝.
- 通过扫描电子显微镜 (SEM) 进行结构分析.
- 福利埃变换红外光谱 (FTIR) 测量结构差异.
- 实验室释放研究在模拟胃液 (SGF) 和模拟肠液 (SIF) 中进行.
主要成果:
- 与传统气凝相比,核心型气凝具有更高的结构均性和多孔性.
- 封装效率对于核心外 (53%) 与传统 (12%) 气凝相比显著更高.
- 核心外气凝在SGF中显示最小的胰岛素释放 (30%),但在一个小时内在SIF中释放了大量的胰岛素 (60%),随后持续释放.
结论:
- 核心的气凝显示出用于口服胰岛素输送的增强载体特性.
- 开发的气凝显示出控制释放短效胰岛素治疗药物的潜力.
- 气凝技术为可注射蛋白质疗法提供了一个有前途的,患者友好的替代方案.
相关概念视频
Insulin Formulations: Types and Delivery
167
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
167
Drug Delivery: Enteral Route
377
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
377


